Moving away from heparin: The new antithrombotic and anti-platelet drugs

L.F. Harris, A.J. Killard

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Heparin is a highly sulphated glycosaminoglycan discovered about 90 years ago, and since then is widely used in medicine as an anticoagulant drug. Antithrombin (AT) is a small protein molecule that inactivates several enzymes of the coagulation system. This book discusses the clinical applications of heparin; new antithrombotic and anti-platelet drugs that can be used instead of heparin; and heparin’s effect on vascular health.
Original languageEnglish
Title of host publicationHeparin Structure Drug Delivery Applications and Clinical Outcomes
PublisherNova Science Publishers, Inc.
Chapter2
Pages21-39
Number of pages18
ISBN (Print)9781631176241 9781631176258
Publication statusPublished - 2014

Fingerprint

Dive into the research topics of 'Moving away from heparin: The new antithrombotic and anti-platelet drugs'. Together they form a unique fingerprint.

Cite this